Hologic Names Two Icahn-Backed Directors to Board

Hologic Names Two Icahn-Backed Directors to Board Play

Dec. 9 (Bloomberg) -- Hologic, a maker of cervical cancer and breast biopsy tools, added two independent directors to its board under an agreement with billionaire investor Carl Icahn. The company also picked a new chief executive officer. Scarlet Fu reports on Bloomberg Television's "In The Loop." (Source: Bloomberg)

  • On Air Now

    Charlie Rose Watch Now

  • Next

    Bloomberg West

blog comments powered by Disqus